{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:31:14Z","timestamp":1794652274239,"version":"4.9.1"},"reference-count":32,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Johannes and Frieda Marohn Foundation","award":["Alz\/Iko \u2013 Spr\u00fc\/2020"],"award-info":[{"award-number":["Alz\/Iko \u2013 Spr\u00fc\/2020"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study determined the effect of amantadine treatment on consciousness in patients with non-traumatic brain injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We pooled individual patient data of five single-centre observational studies to determine the effect of amantadine treatment among patients with ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, community-acquired bacterial meningitis and status epilepticus, admitted between January 2012 and December 2015 and ventilated \u22657\u2009days. Patient selection and multivariable regression modelling were used to adjust for differences in intergroup comparison and for parameters associated with consciousness. Improvement of consciousness 5\u2009days after treatment initiation was defined as primary outcome. Secondary outcomes included Glasgow Coma Scale (GCS) at day 5 and GCS at day 10, rate of ICU delirium, epileptic seizures and all-cause mortality at 90 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 84 of 294 (28.6%) eligible patients received amantadine. Amantadine treatment was associated with improvement of consciousness at day 5 (amantadine: 86.9% vs control: 54.0%; absolute difference: 32.9 (20.0\u201344.2); adjusted OR (aOR): 5.71 (2.50\u201313.05), p&lt;0.001). Secondary outcomes showed differences in GCS 5\u2009days (9 (8\u201311) vs 6 (3\u20139), p&lt;0.001) and GCS 10 days (10(8\u201311) vs 9(6\u201311),p=0.003) after treatment initiation. There were no significant differences regarding all-cause mortality (aOR: 0.89 (0.44\u20131.82), p=0.758) and ICU delirium (aOR: 1.39 (0.58\u20133.31), p=0.462). Rate of epileptic seizures after initiation of amantadine treatment was numerically higher in the amantadine group (amantadine: 10.7% vs control: 3.0%; absolute difference: 7.7 (0.3\u201316.4); aOR: 3.68 (0.86\u201315.71), p=0.079).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Amantadine treatment is associated with improved consciousness among patients with different types of non-traumatic brain injury in this observational cohort analysis. Epileptic seizures should be considered as potential side effects and randomised controlled trials are needed to confirm these findings.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2021-327408","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T18:27:22Z","timestamp":1643308042000},"page":"582-587","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury"],"prefix":"10.1136","volume":"93","author":[{"given":"Lena","family":"R\u00fchl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7630-7880","authenticated-orcid":false,"given":"Joji B","family":"Kuramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen A","family":"Sembill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kallm\u00fcnzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-9668","authenticated-orcid":false,"given":"Dominik","family":"Madzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6020-8290","authenticated-orcid":false,"given":"Stefan T","family":"Gerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Giede-Jeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen B","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1679-9553","authenticated-orcid":false,"given":"Maximilian I","family":"Spr\u00fcgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"2023052906053236000_93.6.582.1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"2023052906053236000_93.6.582.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30034-1"},{"key":"2023052906053236000_93.6.582.3","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000098"},{"key":"2023052906053236000_93.6.582.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.15859","article-title":"Disability-adjusted life-years associated with intracerebral hemorrhage and secondary injury","volume":"4","author":"Haupenthal","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023052906053236000_93.6.582.5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1747493019895662","article-title":"Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage","volume":"16","author":"Spr\u00fcgel","year":"2021","journal-title":"Int J Stroke"},{"key":"2023052906053236000_93.6.582.6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(17)30118-7","article-title":"Severe traumatic brain injury: targeted management in the intensive care unit","volume":"16","author":"Stocchetti","year":"2017","journal-title":"Lancet Neurol"},{"key":"2023052906053236000_93.6.582.7","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261906.93238.72"},{"key":"2023052906053236000_93.6.582.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-013-9925-z"},{"key":"2023052906053236000_93.6.582.9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ana.25969","article-title":"Multicenter validation of the max-ICH score in intracerebral hemorrhage","volume":"89","author":"Sembill","year":"2021","journal-title":"Ann Neurol"},{"key":"2023052906053236000_93.6.582.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004174"},{"key":"2023052906053236000_93.6.582.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30031-6"},{"key":"2023052906053236000_93.6.582.12","first-page":"01","article-title":"Stimulant use to improve wakefulness following brain injury: a survey of the neurocritical care Society","volume":"12","author":"Peoples","year":"2020","journal-title":"EC Neurology"},{"key":"2023052906053236000_93.6.582.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102609"},{"key":"2023052906053236000_93.6.582.14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12028-020-00977-5","article-title":"Amantadine and modafinil as neurostimulants during post-stroke care: a systematic review","volume":"33","author":"Gagnon","year":"2020","journal-title":"Neurocrit Care"},{"key":"2023052906053236000_93.6.582.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.124099"},{"key":"2023052906053236000_93.6.582.16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12028-020-00986-4","article-title":"Amantadine and modafinil as Neurostimulants following acute stroke: a retrospective study of intensive care unit patients","volume":"34","author":"Leclerc","year":"2021","journal-title":"Neurocrit Care"},{"key":"2023052906053236000_93.6.582.17","article-title":"Persistent vegetative state after severe cerebral hemorrhage treated with amantadine: a retrospective controlled study","volume":"99","author":"Gao","year":"2020","journal-title":"Medicine"},{"key":"2023052906053236000_93.6.582.18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/TJAR.2018.20280","article-title":"Can amantadine ameliorate neurocognitive functions after subarachnoid haemorrhage? A preliminary study","volume":"46","author":"Ak\u00e7\u0131l","year":"2018","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"2023052906053236000_93.6.582.19","doi-asserted-by":"publisher","DOI":"10.3109\/02699059409151025"},{"key":"2023052906053236000_93.6.582.20","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1161\/STROKEAHA.118.021614","article-title":"Antiplatelet therapy in primary spontaneous and oral Anticoagulation-Associated intracerebral hemorrhage","volume":"49","author":"Spr\u00fcgel","year":"2018","journal-title":"Stroke"},{"key":"2023052906053236000_93.6.582.21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jama.2019.13014","article-title":"Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar intracerebral hemorrhage","volume":"322","author":"Kuramatsu","year":"2019","journal-title":"JAMA"},{"key":"2023052906053236000_93.6.582.22","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/STROKEAHA.119.026139","article-title":"Heart failure in ischemic stroke: relevance for acute care and outcome","volume":"50","author":"Siedler","year":"2019","journal-title":"Stroke"},{"key":"2023052906053236000_93.6.582.23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000508577","article-title":"Long-term complications and influence on outcome in patients surviving spontaneous subarachnoid hemorrhage","volume":"49","author":"Gerner","year":"2020","journal-title":"Cerebrovasc Dis"},{"key":"2023052906053236000_93.6.582.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90816-0","article-title":"Neutrophil-to-lymphocyte ratio is associated with increased cerebral blood flow velocity in acute bacterial meningitis","volume":"11","author":"Giede-Jeppe","year":"2021","journal-title":"Sci Rep"},{"key":"2023052906053236000_93.6.582.25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-018-2235-2","article-title":"Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus","volume":"22","author":"Mad\u017ear","year":"2018","journal-title":"Crit Care"},{"key":"2023052906053236000_93.6.582.26","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1212\/WNL.0000000000008129","article-title":"Perihemorrhagic edema: revisiting hematoma volume, location, and surface","volume":"93","author":"Spr\u00fcgel","year":"2019","journal-title":"Neurology"},{"key":"2023052906053236000_93.6.582.27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/STROKEAHA.120.029345","article-title":"Impact of statins on hematoma, edema, seizures, vascular events, and functional recovery after intracerebral hemorrhage","volume":"52","author":"Spr\u00fcgel","year":"2021","journal-title":"Stroke"},{"key":"2023052906053236000_93.6.582.28","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319786"},{"key":"2023052906053236000_93.6.582.29","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22 Suppl 3","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2023052906053236000_93.6.582.30","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9695-z"},{"key":"2023052906053236000_93.6.582.31","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200107000-00012"},{"key":"2023052906053236000_93.6.582.32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww199"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-327408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T13:09:46Z","timestamp":1685365786000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-327408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,5,27]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/jnnp-2021-327408"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-327408","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}